137 related articles for article (PubMed ID: 9814553)
21. Gangliosides improve the outcome of experimental allergic neuritis (EAN).
Oderfeld-Nowak B; Brosnan C; Cervone A; Oderfeld J; Ledeen RW
Acta Neurobiol Exp (Wars); 1990; 50(4-5):495-504. PubMed ID: 2130664
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse.
O'Neill JK; Baker D; Turk JL
J Neuroimmunol; 1992 Dec; 41(2):177-87. PubMed ID: 1469077
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS).
Schorlemmer HU; Seiler FR
Drugs Exp Clin Res; 1991; 17(10-11):461-9. PubMed ID: 1841035
[TBL] [Abstract][Full Text] [Related]
24. Delayed type hypersensitivity to gangliosides in the Lewis rat.
Offner H; Standage BA; Burger DR; Vandenbark AA
J Neuroimmunol; 1985 Aug; 9(3-4):147-57. PubMed ID: 2410448
[TBL] [Abstract][Full Text] [Related]
25. SRI 62-834, a cyclic ether analogue of the phospholipid ET-18-OCH3, displays long-lasting beneficial effect in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Comparison with cyclosporin and (Val2)-dihydrocyclosporin effects in clinical, functional and histological studies.
Chabannes D; Ryffel B; Borel JF
J Autoimmun; 1992 Apr; 5(2):199-211. PubMed ID: 1627233
[TBL] [Abstract][Full Text] [Related]
26. Myelin metabolism in vitro in experimental allergic encephalomyelitis.
Smith ME
J Neurochem; 1969 Jul; 16(7):1099-104. PubMed ID: 5796866
[No Abstract] [Full Text] [Related]
27. Experimental allergic encephalomyelitis: changes in growth and proliferation within the draining lymph node following injection of basic encephalitogenic protein in Freund's complete adjuvant.
Matous-Malbohan I; Holub M; Krásenská J; Marĕs V; Lodin Z
Cell Immunol; 1974 Jun; 12(3):350-62. PubMed ID: 4142422
[No Abstract] [Full Text] [Related]
28. Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor.
Mohamed A; Shoker A; Bendjelloul F; Mare A; Alzrigh M; Benghuzzi H; Desin T
Biomed Sci Instrum; 2003; 39():440-5. PubMed ID: 12724933
[TBL] [Abstract][Full Text] [Related]
29. Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat.
Polman CH; Matthaei I; de Groot CJ; Koetsier JC; Sminia T; Dijkstra CD
J Neuroimmunol; 1988 Feb; 17(3):209-16. PubMed ID: 3257496
[TBL] [Abstract][Full Text] [Related]
30. Recurrent experimental allergic encephalomyelitis in the Lewis rat.
McFarlin DE; Blank SE; Kibler RF
J Immunol; 1974 Aug; 113(2):712-5. PubMed ID: 4136044
[No Abstract] [Full Text] [Related]
31. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction.
Willenborg DO
J Immunol; 1979 Sep; 123(3):1145-50. PubMed ID: 313947
[No Abstract] [Full Text] [Related]
32. Serum antibodies against glycosphingolipids in chronic relapsing experimental allergic encephalomyelitis. Demonstration by ELISA and relation to serum in vivo demyelinating activity.
Schwerer B; Kitz K; Lassmann H; Bernheimer H
J Neuroimmunol; 1984 Dec; 7(2-3):107-19. PubMed ID: 6511889
[TBL] [Abstract][Full Text] [Related]
33. Changes of neurotransmitter systems in chronic relapsing experimental allergic encephalomyelitis in rat brain and spinal cord.
Krenger W; Honegger CG; Feurer C; Cammisuli S
J Neurochem; 1986 Oct; 47(4):1247-54. PubMed ID: 2427658
[TBL] [Abstract][Full Text] [Related]
34. Metabolic activity of CNS proteins in rats and monkeys with experimental allergic encephalomyelitis (EAE).
Smith ME; Rauch HC
J Neurochem; 1974 Oct; 23(4):775-83. PubMed ID: 4430917
[No Abstract] [Full Text] [Related]
35. Early detection of liposome brain localization in rat experimental allergic encephalomyelitis.
Rousseau V; Denizot B; Le Jeune JJ; Jallet P
Exp Brain Res; 1999 Apr; 125(3):255-64. PubMed ID: 10229016
[TBL] [Abstract][Full Text] [Related]
36. Cerebral biochemical pathways in experimental autoimmune encephalomyelitis and adjuvant arthritis: a comparative metabolomic study.
Lutz NW; Fernandez C; Pellissier JF; Cozzone PJ; Béraud E
PLoS One; 2013; 8(2):e56101. PubMed ID: 23457507
[TBL] [Abstract][Full Text] [Related]
37. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
Englert D; Hempel K
Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
[TBL] [Abstract][Full Text] [Related]
38. An ultrastructural study of experimental demyelination and remyelination. 3. Chronic experimental allergic encephalomyelitis in the central nervous system.
Prineas J; Raine CS; Wísniewski H
Lab Invest; 1969 Dec; 21(6):472-83. PubMed ID: 5356782
[No Abstract] [Full Text] [Related]
39. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
Holda JH; Silberg D; Swanborg RH
J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
[TBL] [Abstract][Full Text] [Related]
40. Gangliosides suppress the proliferation of autoreactive cells in experimental allergic encephalomyelitis: ganglioside effects on IL-2 activity.
Jackson KM; Yates AJ; Orosz CG; Whitacre CC
Cell Immunol; 1987 Jan; 104(1):169-81. PubMed ID: 2433055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
